About 15.5 million cancer survivors live in the United States, but only recently has attention been paid to their unique needs and the management of their post-cancer care. Both the cancer itself and its treatment can affect long-term health and quality of life. These growing survivor numbers have an impact on post-cancer care, ongoing testing for recurrence, and workforce well-being. The National Alliance of Healthcare Purchaser Coalitions hosted a webinar discussion about the frequency of testing and screening practices following surgery for colorectal cancer.
The webinar featured George J. Chang, MD, MS, from the University of Texas MD Anderson Cancer Center and his PCORI-funded study, which looked at whether more frequent testing was better at spotting tumor recurrence than less frequent surveillance. Chang discussed his findings’ possible impact for employers and influence on medical guidelines, and compare current US practices in relation to other countries.
George J. Chang, MD, MS
Deputy Department Chair, Department of Surgical Oncology, Division of Surgery
University of Texas MD Anderson Cancer Center
PCORI-funded Research Project
Bruce Sherman, MD
Employers Health Coalition and Buck Consultants
Mark Weinstein, JD, CPA
President and Chief Executive Officer, Independent Colleges and Universities Benefits Association, Inc.
Marianne Fazen, PhD
Executive Director, Dallas-Fort Worth Business Group on Health
About this Webinar
This webinar was part of a comprehensive dissemination campaign developed by the National Alliance through a PCORI Engagement Award that began in Spring 2017 to help close the gap between new research findings and their impact on employer stakeholders.